Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 08, 2021, 09:01 ET New Study Helps Forecast Functional Recovery Time and Return to Activities Following Hip Fracture Surgery

For patients undergoing surgery for a hip fracture, there are still unknowns regarding the return to pre-fracture level of function, specifically in...


Jan 08, 2021, 09:00 ET OncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO? Plus OPDIVO? as Neoadjuvant Therapy for Melanoma

OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced the first patient was dosed in OMS-104, an...


Jan 08, 2021, 08:00 ET First Patient Dosed in Biomarker-Guided Phase 3 Study of DB102 (Enzastaurin) in Patients with Newly-Diagnosed Glioblastoma (GBM)

Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative therapies, today announced dosing of the first patient in ...


Jan 07, 2021, 17:30 ET Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency

WINNIPEG, MB, Jan. 7, 2021 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a cardiovascular pharmaceutical...


Jan 07, 2021, 16:13 ET BENEV Announces Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell- derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double blind, Randomized, Split-face

BENEV Company Inc., an FDA Registered cosmeceutical manufacturer of globally recognized medical professional line, along with their Medical Advisory...


Jan 07, 2021, 16:04 ET Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset targeting P. aeruginosa infections

Felix Biotechnology today announced the initiation of CYPHY, a Phase 1/2 investigator-initiated single center trial at Yale University for targeted...


Jan 07, 2021, 15:06 ET A New Target for Malaria Vaccines

An article published in Experimental Biology and Medicine (Volume 246, Issue 1, January, 2021,...


Jan 07, 2021, 12:53 ET Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable...


Jan 07, 2021, 12:15 ET Surface Ophthalmics Previews Important Clinical Progress in 2021

Surface Ophthalmics, Inc., a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases, is...


Jan 07, 2021, 11:00 ET deCODE genetics: Monozygous but not identical

In the article, Differences between germline genomes of monozygotic twins, published in Nature Genetics today scientists at deCODE genetics searched...


Jan 07, 2021, 11:00 ET deCODE genetics: Monocigótico pero no idéntico

En el artículo, Difference between germline genomes of monozygtic twins ("Diferencia entre los genomas de la línea germinal de los gemelos...


Jan 07, 2021, 11:00 ET deCODE genetics: monozigotos, mas n?o idênticos

No artigo: "Diferen?as entre os genomas da linha germinativa de gêmeos monozigóticos", publicado hoje na Nature Genetics, cientistas da deCODE...


Jan 07, 2021, 11:00 ET deCODE genetics : Monozygotes mais pas identiques

Dans l'article, Differences between germline genomes of monozygotic twins, publié aujourd'hui dansNature Genetics, les scientifiques de deCODE...


Jan 07, 2021, 11:00 ET deCODE genetics: monocigótico pero no idéntico

En el artículo, Diferencias entre los genomas germinales de gemelos monocigóticos, publicado en Nature Genetics hoy científicos de deCODE genetics...


Jan 07, 2021, 11:00 ET deCODE genetics: Eineiig aber nicht identisch

In dem heute in Nature Genetics ver?ffentlichten Artikel Differences between germline genomes of monozygotic twins suchten Wissenschaftler von deCODE ...


Jan 07, 2021, 09:21 ET First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom

RhoVac AB ("RhoVac") announces today, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb...


Jan 07, 2021, 09:00 ET Mitsubishi Tanabe Pharma America Revises REFINE-ALS Biomarker Study Process to Enable Remote Participation

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced revisions to the REFINE-ALS biomarker study protocol to address the safety of people...


Jan 07, 2021, 09:00 ET Further Research into Psilocybin Opens New Doors for Treatment

Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and...


Jan 07, 2021, 08:45 ET Risankizumab (SKYRIZI?) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease

AbbVie (NYSE: ABBV) today announced positive results from two Phase 3 induction studies, ADVANCE and MOTIVATE, showing both doses of risankizumab...


Jan 07, 2021, 08:00 ET Dynavax Announces Final Immunogenicity and Interim Safety Results from Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced...


Jan 07, 2021, 08:00 ET GEMoaB Announces Clinical Data Presentations on Their Lead Asset UniCAR-T-CD123 in relapsed/refractory AML at the Upcoming EHA-EBMT 3rd European CAR T-Cell Meeting

GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to- treat cancers, today announced the...


Jan 07, 2021, 08:00 ET LogicBio Announces Extension Of Collaboration With Children's Medical Research Institute

LogicBio Therapeutics, Inc. (LogicBio - Nasdaq: LOGC), a clinical stage genetic medicines company, today announced the expansion of the Company's...


Jan 07, 2021, 08:00 ET Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Plans

Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of...


Jan 07, 2021, 08:00 ET Le GEMoaB annonce la présentation de données cliniques sur son principal actif, UniCAR-T-CD123, dans la LMA récidivante/réfractaire, lors de la troisième réunion européenne des cellules CAR-T de l'EHA-EBMT

GEMoaB, une société biopharmaceutique spécialisée dans le développement d'immunothérapies de nouvelle génération pour les cancers difficiles à...


Jan 07, 2021, 08:00 ET GEMoaB kündigt Pr?sentation klinischer Daten zu ihrem Hauptprodukt UniCAR-T-CD123 bei rezidivierter/refrakt?rer AML auf dem kommenden 3. europ?ischen CAR-T-Zell-Treffen der EHA-EBMT an

GEMoaB, ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Immuntherapien der n?chsten Generation für schwer zu behandelnde...